A collection of thioxanthone derivatives originally designed as photoactive ligands for molecular cage photocatalysis. These compounds share structural similarities with known anticancer agents and may serve as intercalating agents, offering potential applications in oncology and photodynamic therapy.
This offering centers on a library of thioxanthone derivative compounds that were originally synthesized as photoactive ligands for molecular cages used in photocatalysis. Because these compounds share structural similarities with established anticancer agents, they represent a promising starting point for oncology drug discovery and photodynamic therapy development. The compounds were produced through a chemistry-driven synthesis approach, yielding a structurally diverse set of candidates with potential dual utility in catalytic and biomedical applications.
The compounds have been synthesized and characterized at the laboratory scale. Their structural similarity to thioxanthone derivatives with demonstrated preclinical antitumor efficacy provides a strong rationale for further investigation, though dedicated biological validation studies are needed to confirm anticancer and photodynamic therapy potential.
Louisiana State University is a flagship public land-grant university in Baton Rouge, serving a large student body and a comprehensive research enterprise. A research and technology park provides incubator space, corporate labs, and direct access to campus expertise. A statewide extension network and field sites connect companies to real-world testing, and system-wide health sciences partners support clinical collaboration. Gulf Coast location offers access to suppliers, infrastructure, and demonstration sites. Research is backed by federal funding from NSF, NIH, DOE, USDA, and DoD, and a technology transfer office streamlines IP and startup formation.